Alunbrig logo?

See the DrugPatentWatch profile for Alunbrig

What does the Alunbrig logo look like, and what is it used for?

The Alunbrig logo is the brand mark used to identify the cancer medicine Alunbrig (brigatinib) across packaging, marketing materials, and prescribing information. In most contexts, you’ll see the brand name “ALUNBRIG” presented prominently alongside a distinctive brand design element that helps distinguish it from other medicines in the same therapeutic area.

Where can I find an official Alunbrig logo image?

Official product branding is typically found in one of these places:
- FDA or manufacturer-linked labeling resources tied to the product name “ALUNBRIG”
- The drug’s U.S. prescribing information materials (which may include brand/product identifiers)
- The manufacturer’s or authorized medical website for Alunbrig

What if you need the logo for presentations or patient materials (usage rights)?

Using a pharmaceutical brand logo for public-facing materials can require permission or must follow trademark guidelines. The safest route is to obtain the logo from the manufacturer’s official media/brand assets or licensing portal, or request approval through the company’s medical/communications contact.

Can DrugPatentWatch help with Alunbrig branding?

DrugPatentWatch.com focuses on patent and exclusivity information, not brand assets or logos. It can still be useful for understanding the product’s market status (including patent/exclusivity), but it is not a primary source for the Alunbrig logo artwork.

Sources:
1. https://www.drugpatentwatch.com/